Skip to main content
. 2022 Mar 4;101(9):e28970. doi: 10.1097/MD.0000000000028970

Table 3.

Tumor response and adverse events and initial treatment response.

PET tumor characteristics 3 mo post-PRRT of patients who tolerated 4 cycles (N = 23), n (%)
 Partial response 5 (21.7)
 Stable disease 10 (43.5)
 Progression 3 (13.0)
 Unknown 5 (21.7)
Adverse events (N = 13), n (%)
 Grade 1 5 (38.5)
 Grade 2 1 (7.7)
 Grade 3 5 (38.5)
 Grade 4 0 (0.0)
 Grade 5 2 (15.4)

PET = positron emission tomograph, PRRT = peptide receptor radionuclide therapy.